Amedisys, Inc. (NASDAQ:AMED) is CIBRA Capital Ltd's 7th Largest Position

CIBRA Capital Ltd boosted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 359.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 216,775 shares of the health services provider's stock after purchasing an additional 169,616 shares during the period. Amedisys makes up 6.9% of CIBRA Capital Ltd's investment portfolio, making the stock its 7th largest holding. CIBRA Capital Ltd owned about 0.66% of Amedisys worth $20,080,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of AMED. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Amedisys by 56.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after purchasing an additional 120 shares during the period. Fifth Third Bancorp lifted its stake in shares of Amedisys by 68.1% in the first quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after purchasing an additional 141 shares during the period. Xponance Inc. raised its position in Amedisys by 3.5% during the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock worth $395,000 after acquiring an additional 148 shares during the last quarter. Gamco Investors INC. ET AL raised its position in Amedisys by 0.5% during the fourth quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock worth $2,754,000 after acquiring an additional 159 shares during the last quarter. Finally, UMB Bank n.a. raised its position in Amedisys by 100.0% during the first quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock worth $36,000 after acquiring an additional 193 shares during the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Wall Street Zen cut shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th. Royal Bank Of Canada restated an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research report on Wednesday, April 16th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $100.75.

Amedisys Trading Up 0.2%

Shares of NASDAQ:AMED traded up $0.18 during trading on Friday, reaching $96.14. The stock had a trading volume of 355,257 shares, compared to its average volume of 420,526. The business has a fifty day moving average price of $95.61 and a 200-day moving average price of $93.04. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.27. The stock has a market cap of $3.16 billion, a P/E ratio of 35.48, a PEG ratio of 1.31 and a beta of 0.94. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.79% and a return on equity of 12.52%. The business had revenue of $594.78 million during the quarter, compared to analyst estimates of $597.43 million. During the same quarter in the previous year, the business posted $1.03 earnings per share. The company's revenue was up 4.1% on a year-over-year basis. As a group, analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.